Axa’s Stepan Co SCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-10,400
Closed -$1.25M 1312
2021
Q2
$1.25M Hold
10,400
﹤0.01% 963
2021
Q1
$1.32M Hold
10,400
﹤0.01% 924
2020
Q4
$1.24M Hold
10,400
﹤0.01% 935
2020
Q3
$1.13M Hold
10,400
﹤0.01% 919
2020
Q2
$1.01M Buy
+10,400
New +$978K ﹤0.01% 946
2016
Q3
Sell
-47,200
Closed -$2.81M 1324
2016
Q2
$2.81M Hold
47,200
0.01% 679
2016
Q1
$2.61M Buy
47,200
+5,260
+13% +$253K 0.01% 706
2015
Q4
$2.08M Buy
41,940
+24,949
+147% +$1.25M 0.01% 759
2015
Q3
$707K Buy
16,991
+7,600
+81% +$354K ﹤0.01% 977
2015
Q2
$508K Buy
+9,391
New +$463K ﹤0.01% 1082
2013
Q4
Sell
-800
Closed -$46K 1423
2013
Q3
$46K Sell
800
-10,050
-93% -$582K ﹤0.01% 1229
2013
Q2
$603K Buy
+10,850
New +$613K ﹤0.01% 935

Other funds holding SCL

Axa's SCL Position: Q3 2021 in Review

Axa sold out of Stepan Co (SCL) in Q3 2021, closing a stake of 10,400 shares — an estimated $1.25M sold.

Axa first reported a position in SCL in Q2 2013 and held it in 12 quarters. The position peaked at $2.81M in Q2 2016. 203 funds tracked by Wall St. Rank hold SCL as of Q3 2021.

  • Axa reported no remaining Stepan Co position as of Q3 2021 after selling out during the quarter.
  • Axa sold 10,400 Stepan Co shares in Q3 2021, an estimated $1.25M.
  • Axa first reported a position in Stepan Co in Q2 2013 and held it in 12 quarters.
  • Axa's Stepan Co position peaked at $2.81M in Q2 2016.
  • 203 funds tracked by Wall St. Rank held Stepan Co as of Q3 2021.

Based on Axa's 13F filing for Q3 2021, filed 15 Nov 2021.